drugset / Trial / NCT01607320

Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome

NCT01607320 ↗

Terminated 3 enrolled Bruce Lessey
RandomizedParallel-groupSingle-blindTreatment

Summary

This study examines Raloxifene versus Clomiphene to induce ovulation in women with polycystic ovarian syndrome (PCOS).

Timeline

Start
2012-06
Primary completion
2013-03
Completion
2013-03

Outcome

Outcome not reported

Stopped (Enrollment): “Over budget, slow recruitment, and personnel change”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clomiphene Citrate Other / unclassified 100 mg —
Subject Raloxifene Other / unclassified 120 mg Oral